Carisma Therapeutics, Inc.
CARM
$0.4411
-$0.0612-12.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.18% | 15.86% | 40.65% | 43.84% | 22.99% |
| Total Depreciation and Amortization | -60.96% | -7.34% | 6.04% | -64.34% | 140.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.89% | -70.38% | -1.42% | 187.59% | 74.81% |
| Change in Net Operating Assets | 62.33% | 283.11% | -30.60% | -1,197.54% | -77.19% |
| Cash from Operations | 55.11% | 48.11% | 38.00% | 13.09% | 12.18% |
| Capital Expenditure | -- | 100.00% | 100.00% | 57.09% | 87.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3,182.35% | -100.00% | -100.00% | -100.30% | 99.53% |
| Total Debt Issued | -- | -- | -100.00% | 100.00% | -37.18% |
| Total Debt Repaid | 61.10% | -1.02% | 60.08% | 147.33% | -974.17% |
| Issuance of Common Stock | -99.78% | -- | 222.50% | -96.15% | -92.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -146.30% | -713.86% | 77.32% | 102.01% | -98.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.78% | -61.45% | -298.86% | -218.98% | -154.62% |